Overview PREFERENTIAL Study Status: Withdrawn Trial end date: 2021-11-01 Target enrollment: Participant gender: Summary To determine patient preference for the dexamethasone insert or topical prednisolone therapy through at Day 45 as measured by - Modified COMTOL survey. Phase: Phase 2/Phase 3 Details Lead Sponsor: Duke UniversityCollaborator: Ocular Therapeutix, Inc.Treatments: MethylprednisoloneMethylprednisolone AcetateMethylprednisolone HemisuccinatePrednisolonePrednisolone acetatePrednisolone hemisuccinatePrednisolone phosphate